somaxon pharmaceuticals
Events Scheduler
About Us Product Canidates Therapuetic Areas Insomnia Market Investor Releations News Contact Us
Home > Investor Relations > Events Scheduler
Events Scheduler
Upcoming Events
Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.

Past Events
Thomas Weisel Partners Healthcare Conference 2008
Sep 4, 2008 4:25 PM ET
Listen to webcast Webcast
Newsmakers in the BioTech Industry Conference
Sep 4, 2008 3:00 PM ET
Listen to webcast Webcast
Somaxon Pharmaceuticals 2008 Second Quarter Financial Results Conference Call
Aug 7, 2008 1:30 PM PT
Listen to webcast Webcast
FBR Capital Markets 12th Annual Spring Investor Conference
May 28, 2008 - May 29, 2008
Listen to webcast Webcast
Morgan Stanley 2008 Global Healthcare Unplugged Conference
May 1, 2008 5:00 PM ET
Listen to webcast Webcast
Cowen and Company 28th Annual Healthcare Conference
Mar 18, 2008 3:10 PM ET
Listen to webcast Webcast
Somaxon Pharmaceuticals 2007 Fourth Quarter Financial Results Conference Call
Mar 11, 2008 1:30 PM PT
Listen to webcast Webcast
JPMorgan 26th Annual Healthcare Conference
Jan 10, 2008 7:30 AM PT
Listen to webcast Webcast
View Presentation
Somaxon Pharmaceuticals 2007 First Quarter Financial Results Conference Call
May 8, 2007 8:30 AM ET
Listen to webcast Webcast
Somaxon Pharmaceuticals 2006 Fourth Quarter and Full-Year Financial Results Conference Call
Mar 13, 2007 5:30 AM PT
Listen to webcast Webcast
Somaxon Pharmaceuticals Silenor Preclinical Program Update Conference Call
Feb 13, 2007 9:00 AM ET
Listen to webcast Webcast
Somaxon Pharmaceuticals Silenor Phase III Results Conference Call
Dec 18, 2006 6:00 AM PT
Listen to webcast Webcast

Forward-Looking Statements

Somaxon cautions you that statements included in the company’s conference calls, press releases and other materials posted on, or available through, this website that are not a description of historical facts are forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Somaxon that any of its plans will be achieved. Actual results may differ materially from those discussed in the conference calls, press releases and other materials posted on, or available through, this website due to the risks and uncertainties inherent in Somaxon’s business including, without limitation: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its product candidates; unexpected adverse side effects or inadequate therapeutic efficacy of its product candidates that could delay or prevent regulatory approval, product development or commercialization, or that could result in recalls or product liability claims; maintenance and enforcement of Somaxon’s licensing arrangements with various third party licensors; the scope and validity of patent protection for its product candidates; and other risks detailed in Somaxon’s Securities and Exchange Commission filings, including the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Somaxon undertakes no obligation to revise or update such statements to reflect events or circumstances after the date made. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.